Benefit-risk assessment of traditional Chinese medicine preparations of sinomenine using multicriteria decision analysis (MCDA) for patients with rheumatoid arthritis
Abstract Objective A multicriteria decision analysis (MCDA) model was used to evaluate the benefits and risks of traditional Chinese medicine preparations of sinomenine alone or in combination with conventional drugs in the treatment of rheumatoid arthritis (RA) and to provide a basis for the ration...
Saved in:
Main Authors: | Gao Xiang (Author), Min Gao (Author), Huirong Qin (Author), Xiaolan Shen (Author), Huilian Huang (Author), Xiaoqiang Hou (Author), Zhitao Feng (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic review of Janus kinases inhibitors for rheumatoid arthritis: methodology, reporting, and quality of evidence evaluation
by: Xiaolan Shen, et al.
Published: (2024) -
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada
by: Tony Michèle, et al.
Published: (2011) -
Methodological and reporting quality evaluation of meta-analyses on the Chinese herbal preparation Zheng Qing Feng Tong Ning for the treatment of rheumatoid arthritis
by: Mingge Liang, et al.
Published: (2020) -
Computational Prediction of Antiangiogenesis Synergistic Mechanisms of Total Saponins of Panax japonicus Against Rheumatoid Arthritis
by: Xiang Guo, et al.
Published: (2020) -
N-demethylsinomenine metabolite and its prototype sinomenine activate mast cells via MRGPRX2 and aggravate anaphylaxis
by: Youfa Qin, et al.
Published: (2024)